| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72078-025-10 | 72078-025 | HUMAN PRESCRIPTION DRUG | Eptifibatide | eptifibatide | INJECTION, SOLUTION | INTRAVENOUS | 20210401 | N/A | ANDA | ANDA203258 | Mylan Institutional LLC | EPTIFIBATIDE | 2 mg/mL | 1 VIAL in 1 CARTON (72078-025-10) / 10 mL in 1 VIAL |
| 67457-629-10 | 67457-629 | HUMAN PRESCRIPTION DRUG | Eptifibatide | eptifibatide | INJECTION, SOLUTION | INTRAVENOUS | 20181001 | N/A | ANDA | ANDA203258 | Mylan Institutional LLC | EPTIFIBATIDE | 2 mg/mL | 1 VIAL in 1 CARTON (67457-629-10) / 10 mL in 1 VIAL |
| 72078-026-10 | 72078-026 | HUMAN PRESCRIPTION DRUG | Eptifibatide | eptifibatide | INJECTION, SOLUTION | INTRAVENOUS | 20201120 | N/A | ANDA | ANDA203258 | Mylan Institutional LLC | EPTIFIBATIDE | .75 mg/mL | 1 VIAL in 1 CARTON (72078-026-10) / 100 mL in 1 VIAL |
| 67457-630-10 | 67457-630 | HUMAN PRESCRIPTION DRUG | Eptifibatide | eptifibatide | INJECTION, SOLUTION | INTRAVENOUS | 20181001 | N/A | ANDA | ANDA203258 | Mylan Institutional LLC | EPTIFIBATIDE | 2 mg/mL | 1 VIAL in 1 CARTON (67457-630-10) / 100 mL in 1 VIAL |
| 72078-027-10 | 72078-027 | HUMAN PRESCRIPTION DRUG | Eptifibatide | eptifibatide | INJECTION, SOLUTION | INTRAVENOUS | 20210401 | N/A | ANDA | ANDA203258 | Mylan Institutional LLC | EPTIFIBATIDE | 2 mg/mL | 1 VIAL in 1 CARTON (72078-027-10) / 100 mL in 1 VIAL |
| 67457-631-10 | 67457-631 | HUMAN PRESCRIPTION DRUG | Eptifibatide | eptifibatide | INJECTION, SOLUTION | INTRAVENOUS | 20181213 | N/A | ANDA | ANDA203258 | Mylan Institutional LLC | EPTIFIBATIDE | .75 mg/mL | 1 VIAL in 1 CARTON (67457-631-10) / 100 mL in 1 VIAL |